[go: up one dir, main page]

MA26765A1 - Nouveaux esters derives de composes phenyl-cyclohexyl substitues. - Google Patents

Nouveaux esters derives de composes phenyl-cyclohexyl substitues.

Info

Publication number
MA26765A1
MA26765A1 MA26211A MA26211A MA26765A1 MA 26765 A1 MA26765 A1 MA 26765A1 MA 26211 A MA26211 A MA 26211A MA 26211 A MA26211 A MA 26211A MA 26765 A1 MA26765 A1 MA 26765A1
Authority
MA
Morocco
Prior art keywords
substituted phenyl
esters derived
compounds
novel esters
cyclohexyl compounds
Prior art date
Application number
MA26211A
Other languages
English (en)
Inventor
Castillo Nieto Juan Carlos Del
Clotet Joan Huguet
Ramon Amat Elisabet De
Freixa Maria Chalaux
Original Assignee
Vita Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Lab filed Critical Vita Lab
Publication of MA26765A1 publication Critical patent/MA26765A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/40Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/42Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/44Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C219/30Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Nouveaux esters dérivés de composés phényl-cyclohexyl substitués, dérivés du Tramadol, procédé pour leur obtention et utilisation de ces composés pour la fabrication d'un médicament ayant des propriétés analgésiques. Ces nouveaux produits de formule générale (I) présentent une activité analgésique supérieure au tramadol, une toxicité inférieure et une durée d'action supérieure.
MA26211A 1998-11-06 2001-05-23 Nouveaux esters derives de composes phenyl-cyclohexyl substitues. MA26765A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009802329A ES2141688B1 (es) 1998-11-06 1998-11-06 Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.

Publications (1)

Publication Number Publication Date
MA26765A1 true MA26765A1 (fr) 2004-12-20

Family

ID=8305698

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26211A MA26765A1 (fr) 1998-11-06 2001-05-23 Nouveaux esters derives de composes phenyl-cyclohexyl substitues.

Country Status (39)

Country Link
US (1) US6455585B1 (fr)
EP (3) EP1219594B1 (fr)
JP (1) JP2002529442A (fr)
KR (1) KR100453613B1 (fr)
CN (1) CN1176902C (fr)
AP (1) AP1222A (fr)
AT (3) ATE257837T1 (fr)
AU (1) AU755681B2 (fr)
BG (1) BG105556A (fr)
BR (1) BR9915727A (fr)
CA (1) CA2349245A1 (fr)
CR (1) CR6368A (fr)
CU (1) CU23006A3 (fr)
CZ (1) CZ20011500A3 (fr)
DE (3) DE69914231T2 (fr)
DK (3) DK1219623T3 (fr)
EA (1) EA003742B1 (fr)
EE (1) EE200100246A (fr)
ES (4) ES2141688B1 (fr)
GE (1) GEP20033116B (fr)
HR (1) HRP20010412B1 (fr)
HU (1) HUP0104218A3 (fr)
ID (1) ID29017A (fr)
IL (1) IL142592A0 (fr)
IS (1) IS5934A (fr)
MA (1) MA26765A1 (fr)
MX (1) MXPA01004432A (fr)
NO (1) NO20012234D0 (fr)
NZ (1) NZ511739A (fr)
OA (1) OA11672A (fr)
PL (1) PL347492A1 (fr)
PT (3) PT1127871E (fr)
SI (3) SI1219623T1 (fr)
SK (1) SK284068B6 (fr)
TR (3) TR200200415T2 (fr)
UA (1) UA59477C2 (fr)
WO (1) WO2000027799A1 (fr)
YU (1) YU29601A (fr)
ZA (1) ZA200104026B (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2160534B1 (es) * 1999-12-30 2002-04-16 Vita Invest Sa Nuevos esteres derivados de (rr,ss)-2-hidroxibenzoato de 3-(2-dimetilaminometil-1-hidroxiciclohexil) fenilo.
DE10049483A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte 1-Aminobutan-3-ol-Derivate
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
WO2004026291A1 (fr) * 2002-08-28 2004-04-01 Shuyi Zhang Formulations orales d'ibuprofene et de tramadol, methodes de preparation de ces dernieres
EP1562567B1 (fr) 2002-11-22 2017-06-14 Grünenthal GmbH Association d'analgesiques selectionnes et d'inhibiteurs de la cox ii
US20040248979A1 (en) * 2003-06-03 2004-12-09 Dynogen Pharmaceuticals, Inc. Method of treating lower urinary tract disorders
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102004034619A1 (de) * 2004-07-16 2006-02-23 Grünenthal GmbH Substituierte Aminoverbindungen als 5-HT/NA Uptakehemmer
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
US8383152B2 (en) 2008-01-25 2013-02-26 Gruenenthal Gmbh Pharmaceutical dosage form
TWI524904B (zh) 2008-05-09 2016-03-11 歌林達股份有限公司 製備醫藥用固體劑型,尤指錠劑之方法,及製備固體劑型,尤指錠劑之前驅物之方法
NZ596668A (en) 2009-07-22 2013-09-27 Gruenenthal Chemie Oxidation-stabilized tamper-resistant dosage form
JP5667183B2 (ja) 2009-07-22 2015-02-12 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 加熱溶融押出成型した制御放出性投与剤型
EP2383255A1 (fr) 2010-04-28 2011-11-02 Lacer, S.A. Nouveaux composés, synthèse et utilisation dans le traitement de la douleur
MX2013002293A (es) 2010-09-02 2013-05-09 Gruenenthal Gmbh Forma de dosificacion resistente a alteracion que comprende un polimero anionico.
ES2486791T3 (es) 2010-09-02 2014-08-19 Grünenthal GmbH Forma de dosificación resistente a la manipulación que comprende una sal inorgánica
WO2012100423A1 (fr) * 2011-01-27 2012-08-02 Eli Lilly And Company Composés analgésiques, procédés, et formulations
EP2530072A1 (fr) 2011-06-03 2012-12-05 Lacer, S.A. Nouveaux composés, synthèse et utilisation dans le traitement de la douleur
US10702485B2 (en) 2011-07-09 2020-07-07 Syntrix Biosystems Inc. Compositions and methods for overcoming resistance to tramadol
PE20141650A1 (es) 2011-07-29 2014-11-22 Gruenenthal Chemie Tableta a prueba de alteracion que proporciona liberacion inmediata del farmaco
EA201400172A1 (ru) 2011-07-29 2014-06-30 Грюненталь Гмбх Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
WO2013127831A1 (fr) 2012-02-28 2013-09-06 Grünenthal GmbH Forme pharmaceutique inviolable comprenant un composé pharmacologiquement actif et un polymère anionique
ES2692944T3 (es) 2012-04-18 2018-12-05 Grünenthal GmbH Forma de dosificación farmacéutica resistente a la manipulación y resistente a la descarga rápida de la dosis
US9339484B2 (en) * 2012-05-10 2016-05-17 Cellix Bio Private Limited Compositions and methods for the treatment of restless leg syndrome and fibromyalgia
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
BR112015026549A2 (pt) 2013-05-29 2017-07-25 Gruenenthal Gmbh forma de dosagem à prova de violação contendo uma ou mais partículas
US9737490B2 (en) 2013-05-29 2017-08-22 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
AU2014289187B2 (en) 2013-07-12 2019-07-11 Grunenthal Gmbh Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
AU2014356581C1 (en) 2013-11-26 2020-05-28 Grunenthal Gmbh Preparation of a powdery pharmaceutical composition by means of cryo-milling
MX2016014738A (es) 2014-05-12 2017-03-06 Gruenenthal Gmbh Formulacion en capsula de liberacion inmediata resistente a alteraciones que comprende tapentadol.
BR112017021475A2 (pt) 2015-04-24 2018-07-10 Gruenenthal Gmbh forma de dosagem resistente à adulteração (tamper) com liberação imediata e resistência contra extração de solvente
CA2998259A1 (fr) 2015-09-10 2017-03-16 Grunenthal Gmbh Protection contre un surdosage par voie orale a l'aide de formulations a liberation immediate dissuasives d'abus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1199764B (de) * 1963-04-02 1965-09-02 Gruenenthal Chemie Verfahren zur Herstellung von basisch substituierten Phenolaethern
US3652589A (en) * 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
DE19609847A1 (de) * 1996-03-13 1997-09-18 Gruenenthal Gmbh Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe

Also Published As

Publication number Publication date
UA59477C2 (uk) 2003-09-15
AP1222A (en) 2003-11-06
SK284068B6 (sk) 2004-09-08
EP1219623A1 (fr) 2002-07-03
GEP20033116B (en) 2003-11-25
EP1127871A1 (fr) 2001-08-29
DK1127871T3 (da) 2003-11-24
ES2213732T3 (es) 2004-09-01
TR200200416T2 (tr) 2003-01-21
ES2213731T3 (es) 2004-09-01
CZ20011500A3 (cs) 2001-09-12
CR6368A (es) 2002-04-08
DE69911235D1 (de) 2003-10-16
CN1176902C (zh) 2004-11-24
EA200100476A1 (ru) 2002-02-28
KR20010080942A (ko) 2001-08-25
EP1219594B1 (fr) 2004-01-14
DE69911235T2 (de) 2004-07-01
EA003742B1 (ru) 2003-08-28
ES2141688B1 (es) 2001-02-01
MXPA01004432A (es) 2002-09-18
EP1219623B1 (fr) 2004-01-14
DE69914229T2 (de) 2004-12-09
PT1127871E (pt) 2003-12-31
AU755681B2 (en) 2002-12-19
CN1325377A (zh) 2001-12-05
SI1219623T1 (en) 2004-06-30
CU23006A3 (es) 2004-12-17
HUP0104218A2 (hu) 2002-03-28
ES2207298T3 (es) 2004-05-16
PT1219594E (pt) 2004-04-30
HRP20010412A2 (en) 2002-12-31
YU29601A (sh) 2003-04-30
EP1127871B1 (fr) 2003-09-10
SI1219594T1 (en) 2004-06-30
ATE257817T1 (de) 2004-01-15
JP2002529442A (ja) 2002-09-10
DE69914231T2 (de) 2004-11-11
BG105556A (en) 2001-12-29
IS5934A (is) 2001-05-03
SK5842001A3 (en) 2001-12-03
DK1219594T3 (da) 2004-04-19
PT1219623E (pt) 2004-04-30
NO20012234L (no) 2001-05-04
WO2000027799A1 (fr) 2000-05-18
KR100453613B1 (ko) 2004-10-20
ATE249418T1 (de) 2003-09-15
NZ511739A (en) 2002-11-26
OA11672A (en) 2005-01-12
PL347492A1 (en) 2002-04-08
IL142592A0 (en) 2002-03-10
ATE257837T1 (de) 2004-01-15
ZA200104026B (en) 2002-05-17
ES2141688A1 (es) 2000-05-16
ID29017A (id) 2001-07-26
EP1219594A1 (fr) 2002-07-03
DK1219623T3 (da) 2004-04-19
EE200100246A (et) 2002-12-16
DE69914229D1 (de) 2004-02-19
SI1127871T1 (en) 2004-02-29
NO20012234D0 (no) 2001-05-04
US6455585B1 (en) 2002-09-24
TR200200415T2 (tr) 2002-06-21
AU1047300A (en) 2000-05-29
HUP0104218A3 (en) 2002-11-28
TR200101160T2 (tr) 2002-01-21
CA2349245A1 (fr) 2000-05-18
DE69914231D1 (de) 2004-02-19
HRP20010412B1 (en) 2004-04-30
BR9915727A (pt) 2001-09-04

Similar Documents

Publication Publication Date Title
MA26765A1 (fr) Nouveaux esters derives de composes phenyl-cyclohexyl substitues.
MA26862A1 (fr) Nouveaux esters derivant de (rr,ss)-3-(2-dimethylaminomethyl-1-hydroxycyclohexyl) phennyle 2-hydroxybenzoate
MA26963A1 (fr) Composes derives de benzothiophene, procede de leur preparation et leur utilisation.
KR102316234B1 (ko) 히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 유도체 화합물 및 이를 포함하는 약제학적 조성물
DZ3030A1 (fr) Procédé et produits intermédiaires pour la préparation de composés anti-cancéreux.
NZ308619A (en) N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists
DZ3052A1 (fr) Composés nouveaux inhibiteurs de métalloprotéases,procédé pour leur préparation et compositions pha rmaceutiques les contenant.
WO2001019798A3 (fr) Inhibiteurs du facteur xa
FI930455A0 (fi) Foereningar och foerfaranden foer inhibering av gen expression
NO20005669L (no) Nye derivater av 3,3-difenylpropylaminer
HUT76657A (en) 2-(1',2',4'-triazol-3'-yloxymethylene)-anilides, process for producing them and their use as pestcontrol agents
KR830007615A (ko) 피레트 린산과 연관된 시클로프로판 카복실산 에스테르와 그의 제조방법
CA2032988A1 (fr) Procede de preparation de derives de la 1-phenyl imidazoline 2,5-dione
CN1284063A (zh) 新化合物
EP1207157A4 (fr) Derives de benzylthiazolidine-2,4-dione substitues
EP0658585A3 (fr) Dérivés d'aminophénylalanine, procédé pour leur, production leur usage et agents contenant ceux-ci comme anticoagulants.
WO2005058812A3 (fr) Synthese de la prostaglandine
CA2214322A1 (fr) Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2858321B1 (fr) Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2275192A1 (fr) Nouveau procede de preparation de derives de la 4-phenyl-1,2,3,6-tetrahydropyridine et les produits intermediaires mis en oeuvre
NO177059C (no) Fremgangsmåte for fremstilling av et polypropylenmateriale podet med en epoksyalkylakrylatforbindelse
WO2000018722A3 (fr) Nouveaux derives de la 6-(4-phenylbutoxy)hexylamine et procede d'obtention de salmeterol
FR2526428A1 (fr) Iminoderives substitues du 4h-2,3-dihydrobenzopyranne et du 4h-2,3-dihydrobenzothiopyranne, leur procede de preparation et leur utilisation comme depresseurs du systeme nerveux central
EP0240978A3 (fr) Composés-éthers, procédé pour leur préparation, les compositions les contenant et leur utilisation
DZ3096A1 (fr) Procédé pour la préparation de dérivés de pyrazoloÄ4,3-DÜpyrimidine-7-one-3-pyridylsulfonyle, et intermédiaires utilisés.